Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Agenesis of the superior vena cava (SVC) is a rare congenital anomaly of the great veins characterized by unilateral or bilateral complete absence of the SVC. Unilateral agenesis is mainly asymptomatic (most of the time diagnosed incidentally) and patients usually have otherwise normal heart structure. Bilateral agenesis, however, is frequently associated with other congenital cardiac anomalies and/or conduction abnormalities (such as tetralogy of Fallot, atrial septal defect) and typically present symptoms of SVC syndrome.
Biomarker and diagnostic research for agenesis of the superior vena cava has been reported in the published literature.
No clinical trials have been registered for agenesis of the superior vena cava.
257 publications have been identified in PubMed for agenesis of the superior vena cava. Kisho has analyzed 27 by research type. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (19%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 44% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:39 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about agenesis of the superior vena cava
Research summaries |
5 |
19% |
Clinical study results | 3 | 11% |
Disease patterns and progression | 3 | 11% |
Testing and diagnosis research | 2 | 7% |
Laboratory research | 1 | 4% |
New treatment approaches | 1 | 4% |
Sayıcı Uİ (2026). [PMID: 41940511](https://pubmed.ncbi.nlm.nih.gov/41940511/). *Cardiol Young*. [Case Report / Case Series]
Sani C (2026). [PMID: 42109984](https://pubmed.ncbi.nlm.nih.gov/42109984/). *Cureus*. [Case Report / Case Series]
Li TG (2025). [PMID: 40470892](https://pubmed.ncbi.nlm.nih.gov/40470892/). *J Obstet Gynaecol*. [Epidemiology / Natural History]
Vázquez-Calvo S (2025). [PMID: 41117094](https://pubmed.ncbi.nlm.nih.gov/41117094/). *Pacing Clin Electrophysiol*. [Case Report / Case Series]
Nolfi MB (2025). [PMID: 40454318](https://pubmed.ncbi.nlm.nih.gov/40454318/). *J Surg Case Rep*. [Case Report / Case Series]
Li TG (2025). [PMID: 39945114](https://pubmed.ncbi.nlm.nih.gov/39945114/). *J Ultrasound Med*. [Diagnostic / Biomarker]
Toprak MHH (2025). [PMID: 41217972](https://pubmed.ncbi.nlm.nih.gov/41217972/). *Braz J Cardiovasc Surg*. [Epidemiology / Natural History]
Yoshida E (2025). [PMID: 41378059](https://pubmed.ncbi.nlm.nih.gov/41378059/). *J Arrhythm*. [Clinical Trial Publication]
Bieling F (2025). [PMID: 40154546](https://pubmed.ncbi.nlm.nih.gov/40154546/). *Thorac Cardiovasc Surg*. [Clinical Trial Publication]
Daire E (2025). [PMID: 41165794](https://pubmed.ncbi.nlm.nih.gov/41165794/). *Pediatr Cardiol*. [Epidemiology / Natural History]